Fibroblast growth factor receptor 4 polymorphism is associated with liver cirrhosis in hepatocarcinoma

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Sheu, Ming Jen ^a   Hsieh, Ming Ju ^b,c   Chiang, Whei Ling ^c,d   Yang, Shun Fa ^c,d   Lee, Hsiang Lin ^c,d   Lee, Liang Ming ^e   Yeh, Chao Bin ^c,d  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA FETOPROTEIN; ASPARTATE AMINOTRANSFERASE; FIBROBLAST GROWTH FACTOR RECEPTOR 4; DNA;

ADULT; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; FEMALE; FIBROBLAST GROWTH FACTOR RECEPTOR 4 GENE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; SINGLE NUCLEOTIDE POLYMORPHISM; TAIWANESE; AGED; ALLELE; ASIAN CONTINENTAL ANCESTRY GROUP; CANCER STAGING; CASE CONTROL STUDY; COMPLICATION; GENETICS; ISOLATION AND PURIFICATION; LIVER TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; TAIWAN;

ADULT; AGED; ALLELES; ALPHA-FETOPROTEINS; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; DNA; FEMALE; GENOTYPE; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; POLYMORPHISM, SINGLE NUCLEOTIDE; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 4; RISK FACTORS; TAIWAN;

EID: 84928889791     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0122961     Document Type: Article

References (39)

1. Zhuang L, Zeng X, Yang Z, Meng Z. Effect and safety of interferon for hepatocellular carcinoma: a systematic review and meta-analysis. PLoS One 2013; 8:e61361. doi: 10.1371/journal.pone.0061361 PMID: 24069133
2. Weinmann A, Koch S, Niederle IM, Schulze-Bergkamen H, Konig J, Hoppe-Lotichius M, et al. Trends in epidemiology, treatment, and survival of hepatocellular carcinoma patients between 1998 and 2009: an analysis of 1066 cases of a German HCC Registry. J Clin Gastroenterol 2014;, 48:279-289. doi: 10.1097/MCG.0b013e3182a8a793 PMID: 24045276
3. Huang YW, Wang TC, Lin SC, Chang HY, Chen DS, Hu JT, et al. Increased risk of cirrhosis and its decompensation in chronic hepatitis B patients with newly diagnosed diabetes: a nationwide cohort study. Clin Infect Dis 2013; 57:1695-1702. doi: 10.1093/cid/cit603 PMID: 24051864
4. Wu CS, Yen CJ, Chou RH, Li ST, Huang WC, Ren CT, et al. Cancer-associated carbohydrate antigens as potential biomarkers for hepatocellular carcinoma. PLoS One 2012; 7:e39466. doi: 10.1371/journal.pone.0039466 PMID: 22808038
5. Chien MH, Yeh CB, Li YC, Wei LH, Chang JH, Peng YT, et al. Relationship of interleukin-8 gene polymorphisms with hepatocellular carcinoma susceptibility and pathological development. J Surg Oncol 2011; 104:798-803. doi: 10.1002/jso.22037 PMID: 21780129
6. Zhong S, Chen Z, Xu J, Li W, Zhao J. Pre-mir-27a rs895819 polymorphism and cancer risk: a meta-analysis. Mol Biol Rep 2013; 40:3181-3186. doi: 10.1007/s11033-012-2392-3 PMID: 23266669
7. Hsieh MC, Hsu HT, Hsiao PC, Yang SF, Yeh CB, Bien MY, et al. Role of VEGF-C gene polymorphisms in susceptibility to hepatocellular carcinoma and its pathological development. J Clin Lab Anal 2014; 28:237-244. doi: 10.1002/jcla.21672 PMID: 24478168
8. Gospodarowicz D, Rudland P, Lindstrom J, Benirschke K. Fibroblast growth factor: its localization, purification, mode of action, and physiological significance. Adv Metab Disord 1975; 8:301-335. PMID: 173161
9. Tiong KH, Mah LY, Leong CO. Functional roles of fibroblast growth factor receptors (FGFRs) signaling in human cancers. Apoptosis 2013; 18:1447-1468. doi: 10.1007/s10495-013-0886-7 PMID: 23900974
10. Trueb B. Biology of FGFRL1, the fifth fibroblast growth factor receptor. Cell Mol Life Sci 2011; 68:951-964. doi: 10.1007/s00018-010-0576-3 PMID: 21080029
11. Eswarakumar VP, Lax I, Schlessinger J. Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev 2005; 16:139-149. PMID: 15863030
12. Wang J, Stockton DW, Ittmann M. The fibroblast growth factor receptor-4 Arg388 allele is associated with prostate cancer initiation and progression. Clin Cancer Res 2004; 10:6169-6178. PMID: 15448004
13. Kan M, Wu X, Wang F, McKeehan WL. Specificity for fibroblast growth factors determined by heparan sulfate in a binary complex with the receptor kinase. J Biol Chem 1999; 274:15947-15952. PMID: 10336501
14. Lin BC, Wang M, Blackmore C, Desnoyers LR. Liver-specific activities of FGF19 require Klotho beta. J Biol Chem 2007; 282:27277-27284. PMID: 17627937
15. Ho HK, Pok S, Streit S, Ruhe JE, Hart S, Lim KS, et al. Fibroblast growth factor receptor 4 regulates proliferation, anti-apoptosis and alpha-fetoprotein secretion during hepatocellular carcinoma progression and represents a potential target for therapeutic intervention. J Hepatol 2009; 50:118-127. doi: 10.1016/j.jhep.2008.08.015 PMID: 19008009
16. Rezvani M, Wilde J, Vitt P, Mailaparambil B, Grychtol R, Krueger M, et al. Association of a FGFR-4 gene polymorphism with bronchopulmonary dysplasia and neonatal respiratory distress. Dis Markers 2013; 35:633-640. doi: 10.1155/2013/932356 PMID: 24288432
17. Ma Z, Tsuchiya N, Yuasa T, Inoue T, Kumazawa T, Narita S, et al. Polymorphisms of fibroblast growth factor receptor 4 have association with the development of prostate cancer and benign prostatic hyperplasia and the progression of prostate cancer in a Japanese population. Int J Cancer 2008; 123:2574-2579. doi: 10.1002/ijc.23578 PMID: 18756523
18. Xu W, Li Y, Wang X, Chen B, Wang Y, Liu S, et al. FGFR4 transmembrane domain polymorphism and cancer risk: a meta-analysis including 8555 subjects. Eur J Cancer 2010; 46:3332-3338. doi: 10.1016/j.ejca.2010.06.017 PMID: 20638838
19. FitzGerald LM, Karlins E, Karyadi DM, Kwon EM, Koopmeiners JS, Stanford JL, et al. Association of FGFR4 genetic polymorphisms with prostate cancer risk and prognosis. Prostate Cancer Prostatic Dis 2009; 12:192-197. doi: 10.1038/pcan.2008.46 PMID: 18762813
20. Agarwal D, Pineda S, Michailidou K, Herranz J, Pita G, Moreno LT, et al. FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium. Br J Cancer 2014; 110:1088-1100. doi: 10.1038/bjc.2013.769 PMID: 24548884
21. Vauthey JN, Lauwers GY, Esnaola NF, Do KA, Belghiti J, Mirza N, et al. Simplified staging for hepatocellular carcinoma. J Clin Oncol 2002; 20:1527-1536. PMID: 11896101
22. Chen CJ, Yu MW, Liaw YF. Epidemiological characteristics and risk factors of hepatocellular carcinoma. J Gastroenterol Hepatol 1997; 12:S294-308. PMID: 9407350
23. Chen TH, Chen CJ, Yen MF, Lu SN, Sun CA, Huang GT, et al. Ultrasound screening and risk factors for death from hepatocellular carcinoma in a high risk group in Taiwan. Int J Cancer 2002; 98:257-261. PMID: 11857416
24. Tsai MC, Kee KM, Chen YD, Lin LC, Tsai LS, Chen HH, et al. Excess mortality of hepatocellular carcinoma and morbidity of liver cirrhosis and hepatitis in HCV-endemic areas in an HBV-endemic country: geographic variations among 502 villages in southern Taiwan. J Gastroenterol Hepatol 2007; 22:92-98. PMID: 17201888
25. Schwarz KB. Oxidative stress during viral infection: a review. Free Radic Biol Med 1996; 21:641-649. PMID: 8891667
26. Mansouri A, Fromenty B, Berson A, Robin MA, Grimbert S, Beaugrand M, et al. Multiple hepatic mitochondrial DNA deletions suggest premature oxidative aging in alcoholic patients. J Hepatol 1997; 27:96-102. PMID: 9252080
27. Merican I, Guan R, Amarapuka D, Alexander MJ, Chutaputti A, Chien RN, et al. Chronic hepatitis B virus infection in Asian countries. J Gastroenterol Hepatol 2000; 15:1356-1361. PMID: 11197043
28. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004; 11:97-107. PMID: 14996343
29. Jacquemier J, Adelaide J, Parc P, Penault-Llorca F, Planche J, deLapeyriere O, et al. Expression of the FGFR1 gene in human breast-carcinoma cells. Int J Cancer 1994; 59:373-378. PMID: 7927944
30. Penault-Llorca F, Bertucci F, Adelaide J, Parc P, Coulier F, Jacquemier J, et al. Expression of FGF and FGF receptor genes in human breast cancer. Int J Cancer 1995; 61:170-176. PMID: 7705943
31. Jaakkola S, Salmikangas P, Nylund S, Partanen J, Armstrong E, Pyrhonen S, et al. Amplification of fgfr4 gene in human breast and gynecological cancers. Int J Cancer 1993; 54:378-382. PMID: 8099571
32. Shin EY, Lee BH, Yang JH, Shin KS, Lee GK, Yun HY, et al. Up-regulation and co-expression of fibroblast growth factor receptors in human gastric cancer. J Cancer Res Clin Oncol 2000; 126:519-528. PMID: 11003564
33. Tsou AP, Wu KM, Tsen TY, Chi CW, Chiu JH, Lui WY, et al. Parallel hybridization analysis of multiple protein kinase genes: identification of gene expression patterns characteristic of human hepatocellular carcinoma. Genomics 1998; 50:331-340. PMID: 9676427
34. Ansell A, Farnebo L, Grenman R, Roberg K, Thunell LK. Polymorphism of FGFR4 in cancer development and sensitivity to cisplatin and radiation in head and neck cancer. Oral Oncol 2009; 45:23-29. doi: 10.1016/j.oraloncology.2008.03.007 PMID: 18487077
35. Yang Y, Zhou Y, Lu M, An Y, Li R, Chen Y, et al. Association between fibroblast growth factor receptor 4 polymorphisms and risk of hepatocellular carcinoma. Mol Carcinog 2012; 51:515-521. doi: 10.1002/mc.20805 PMID: 21656577
36. Yu C, Wang F, Jin C, Wu X, Chan WK, McKeehan WL. Increased carbon tetrachloride-induced liver injury and fibrosis in FGFR4-deficient mice. Am J Pathol 2002; 161:2003-2010. PMID: 12466116
37. Giannini E, Risso D, Botta F, Chiarbonello B, Fasoli A, Malfatti F, et al. Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease. Arch Intern Med 2003; 163:218-224. PMID: 12546613
38. Shen YY, Lu YC, Shen DP, Liu YJ, Su XY, Zhu GS, et al. Fibroblast growth factor receptor 4 Gly388Arg polymorphism in Chinese gastric cancer patients. World J Gastroenterol 2013; 19:4568-4575. doi: 10.3748/wjg.v19.i28.4568 PMID: 23901234
39. Chen Z, Xie B, Zhu Q, Xia Q, Jiang S, Cao R, et al. FGFR4 and TGF-beta1 expression in hepatocellular carcinoma: correlation with clinicopathological features and prognosis. Int J Med Sci 2013; 10:1868-1875. doi: 10.7150/ijms.6868 PMID: 24324363